Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest
Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest
3 of Wall Street’s Favorite Stocks We Approach with Caution
3 of Wall Street’s Favorite Stocks We Approach with Caution
3 Reasons to Avoid SUPN and 1 Stock to Buy Instead
3 Reasons to Avoid SUPN and 1 Stock to Buy Instead
1 Cash-Heavy Stock on Our Watchlist and 2 Facing Challenges
1 Cash-Heavy Stock on Our Watchlist and 2 Facing Challenges
Supernus Pharmaceuticals to Participate in June Investor Conferences
ROCKVILLE, Md., May 27, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central...
3 Stocks Under $50 with Open Questions
3 Stocks Under $50 with Open Questions
3 Small-Cap Stocks That Concern Us
3 Small-Cap Stocks That Concern Us
3 Growth Stocks We Approach with Caution
3 Growth Stocks We Approach with Caution
5 Revealing Analyst Questions From Supernus Pharmaceuticals’s Q1 Earnings Call
5 Revealing Analyst Questions From Supernus Pharmaceuticals’s Q1 Earnings Call
Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today
Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today